机构:[1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu 610041, China.四川大学华西医院[2]Department of Rehabilitation, the Affiliated Hospital of Southwest Medical University, Luzhou 646000, China.
This study was supported by the Luzhou City Science and
Technology Bureau (No. 2020LZXNYDJ10 and
2020LZXNYDJ14) and Cooperation Project between the
Second People’s Hospital of Deyang and Southwest
Medical University (No. 2022DYEXNYD002).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类|2 区医学
小类|3 区肿瘤学
最新[2023]版:
大类|2 区医学
小类|3 区肿瘤学
第一作者:
第一作者机构:[1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu 610041, China.[2]Department of Rehabilitation, the Affiliated Hospital of Southwest Medical University, Luzhou 646000, China.[*1]Department of Rehabilitation, the Affiliated Hospital of Southwest Medical University, Luzhou 646000, China.[*2]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu 610041, China
共同第一作者:
通讯作者:
通讯机构:[1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu 610041, China.[2]Department of Rehabilitation, the Affiliated Hospital of Southwest Medical University, Luzhou 646000, China.[*1]Department of Rehabilitation, the Affiliated Hospital of Southwest Medical University, Luzhou 646000, China.[*2]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu 610041, China
推荐引用方式(GB/T 7714):
Feng Dechao,Li Dengxiong,Xiao Yuhan,et al.Focal ablation therapy presents promising results for selectively localized prostate cancer patients[J].Chinese Journal of Cancer Research.2023,35(4):424-430.doi:10.21147/j.issn.1000-9604.2023.04.08.
APA:
Feng Dechao,Li Dengxiong,Xiao Yuhan,Wu Ruicheng,Wang Jie&Zhang Chi.(2023).Focal ablation therapy presents promising results for selectively localized prostate cancer patients.Chinese Journal of Cancer Research,35,(4)
MLA:
Feng Dechao,et al."Focal ablation therapy presents promising results for selectively localized prostate cancer patients".Chinese Journal of Cancer Research 35..4(2023):424-430